Malignant lymphomas in transplantation patients: a review of the world experience
- PMID: 4909379
- PMCID: PMC2965461
Malignant lymphomas in transplantation patients: a review of the world experience
Abstract
Malignant lymphomas developed in 9 renal homograft recipients treated at widely separated transplantation centers. The development of these tumors appears to be an indirect complication of organ transplantation and/or the measures taken to prevent rejection. A further complication may be an increased incidence of epithelial tumors. It also seems likely that immune paralysis may accelerate the growth of metastases.
References
-
- Agosin M, Christen R, Badinez O, Gasic G, Neghme A, Pizarro O, Jarpa A. Cortisone induced metastases of adenocarcinoma in mice. Proc. Soc. Exp. Biol. Med. 1952;80:128. - PubMed
-
- Albert D, Ziedman I. Relation of glucocorticoid activity of steroids to number of metastases. Cancer Res. 1962;22:1297. - PubMed
-
- Alford TC, Stineburner LL, Hollinshead AC. Effect of spleen and lymph node removal on adenovirus tumor growth. Arch. Surg. 1966;93:166. - PubMed
-
- Allison AC, Berman LD, Levey RH. Increased tumor induction by adenovirus type 12 in thymectomized mice and mice treated with antilymphocyte serum. Nature. 1967;215:185. - PubMed
-
- Allison AC, Law LW. Effects of antilymphocyte serum on virus oncogenesis. Proc. Soc. Exp. Biol. Med. 1968;127:207. - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources